Please activate JavaScript!
Please install Adobe Flash Player, click here for download

NTD_Clienttevredenheid_DEF

36. Christensen TD, Larsen TB. Precision and accuracy of point-of-care testing coagulometers used for self- testing and self-management of oral anticoagulation therapy. J Thromb Haemost. 2012;10:251–60. 37. Sharma P, Scotland G, Cruickshank M, et al. Clinical and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy compared with standard UK practice: systematic review and economic evaluation. Aberdeen HTA Group, Institute of Applied Health Sciences, University of Aberdeen, 2013. Available from http://www.nice.org.uk/nicemedia/live/14091/ 66498/66498.pdf. Accessed May 2014. 38. Azarnoush K, Camilleri L, Aublet-Cuvelier B, et al. Results of the first randomized French study evaluating self-testing of the international normalized ratio. J Heart Valve Dis. 2011;20(5):518–25. 39. Hemkens LG, Hilden KM, Hartschen S, et al. A randomized trial comparing INR monitoring devices in patients with anticoagulation self- management: evaluation of a novel error-grid approach. J Thromb Thrombolysis. 2008;26:22–30. 40. Lam J, Schulman S, Witt DM, Vandvik PO, Qayyum F, Holbrook AM. Anticoagulation control with daily low-dose vitamin K to reduce clinically adverse outcomes and international normalized ratio variability: a systematic review and meta-analysis. Pharmacotherapy. 2013;33(11):1184–90. Adv Ther

Pages Overview